Understanding Migraines and MS: What You Need to Know

Understanding Migraines and MS: What You Need to Know
Credibility
Interest
Key Takeaway

Migraines are more likely to happen around the time MS symptoms start, but they don't cause MS.

What They Found

The study looked at people with MS and compared them to others without it. They found that about 21% of people who developed MS also had migraines around the same time or before their first MS symptom. This was a bit higher than the 18% of people without MS who had migraines. Interestingly, migraines were more common in MS patients when looking at those who had migraines just before their MS symptoms started. However, having migraines didn’t mean you would definitely get MS; they are just part of the symptoms that show up together.

Who Should Care and Why

If you have MS or care for someone with it, knowing this can help you understand that migraines might be a sign of MS beginning, but they aren't the cause. It’s like how a raincoat is often seen when it’s about to rain, but wearing it doesn’t make it rain. For patients, this means that if migraines happen, it’s important to talk to your doctor, but don’t panic thinking it means MS will develop. Caregivers should also be aware of this connection, as it can help them support their loved ones better. Overall, this understanding can help in managing symptoms and seeking appropriate treatment.

Important Considerations

The study looked at a specific group of people, so the results may not apply to everyone with MS. Also, the findings suggest a link but don’t prove that migraines cause MS or are a warning sign. It’s important for patients and caregivers to keep this in mind when discussing symptoms with their doctors.

AI-generated summary — for informational purposes only, not medical advice

Article Topics:
Multiple sclerosisheadachemigraine disordersprodromal symptoms

You May Also Like

Gut Bacteria and MS: What You Need to Know
Gut Bacteria and MS: What You Need to Know

12/31/2026

Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li

Read More
A harmful immune cell linked to MS and past CMV infection
A harmful immune cell linked to MS and past CMV infection

5/1/2026

Study finds a brain‑seeking CD4 killer cell tied to MS and CMV exposure that may resist some treatme

Read More
After Optic Neuritis: The Eye Layer Most Damaged
After Optic Neuritis: The Eye Layer Most Damaged

5/1/2026

Study shows after optic neuritis the ganglion cell layer (GCL) loses more tissue than the inner plex

Read More
CD29: A Blood Clue to MS B Cells and Treatment Response
CD29: A Blood Clue to MS B Cells and Treatment Response

5/1/2026

Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in

Read More
Spinal Fluid Proteins Linked to Early Nerve Damage in MS
Spinal Fluid Proteins Linked to Early Nerve Damage in MS

5/1/2026

Study finds specific spinal fluid proteins tied to early nerve damage in active MS, highlighting imm

Read More
What MS Patients Should Know About PML and Recovery
What MS Patients Should Know About PML and Recovery

5/1/2026

Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes

Read More
Understanding MS Research

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Multiple sclerosis (Houndmills, Basingstoke, England) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.